XRAY 240816 25.00C (XRAY240816C25000) Stock Options, News & Quotes

US OptionsDetailed Quotes

XRAY240816C25000

Watchlist

0.55
+0.10+22.22%

15min DelayClose Aug 16 16:00 ET

0.55High0.35Low

Intraday

5D
Daily

News

DENTSPLY SIRONA Inc. (XRAY): Hedge Funds Are Bullish on This 3D Printing and Additive Manufacturing Stock Now
Yahoo FinanceAug 11 04:37 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: DENTSPLY SIRONA (XRAY), United Therapeutics (UTHR) and Jazz Pharmaceuticals (JAZZ)
TipRanksAug 5 02:44 ET · Ratings
Earnings Miss: DENTSPLY SIRONA Inc. Missed EPS And Analysts Are Revising Their Forecasts
Yahoo FinanceAug 3 08:26 ET
Express News | Dentsply Sirona Inc : Barrington Research Cuts Target Price to $36 From $38
ReutersAug 2 02:34 ET
Barrington Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $36
Moomoo NewsAug 1 12:31 ET · Ratings
DENTSPLY SIRONA: A Buy Rating With Long-Term Growth Potential Despite Short-Term Setbacks
TipRanksAug 1 12:05 ET · Ratings

Comments

Moomoo AI

Feb 16 08:24

The company's low growth and lack of profits have led to a stock price drop. A revenue growth acceleration might boost the share price. However, the real benefit for shareholders will be if the company starts making profits. Despite recent gains, the returns over the last three years have been disappointing.

DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago

Moomoo AI

Jan 29 07:51

DENTSPLY SIRONA's decreasing capital employment and flat returns are concerning. The stock's decline may reflect investor pessimism about these trends. The analysis does not see the traits of a multi-bagger in this stock.

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Moomoo AI

Dec 24, 2023 08:55

DENTSPLY SIRONA's decision to pay a dividend amidst a reported loss is unsettling. It's not an ideal choice for long-term buy and hold investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Goes Ex-Dividend Soon

Moomoo AI

Dec 18, 2023 13:16

Investors predict limited future growth for the company, reflected by its low P/S ratio. The pessimism around its revenue prospect contributes to its undervalued stock.

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Moomoo AI

Nov 28, 2023 05:33

DENTSPLY SIRONA, currently undervalued with steady price trends, could make a solid investment. Despite modest growth projections, aspects like capital structure and management track record could be behind its undervaluation.

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$31.48?